FDA considers expanded use of HPV vaccine

Mar 20, 2008

Pharmaceutical manufacturer Merck & Co. Inc. said the U.S. Food and Drug Administration will consider expanding the use of its cervical cancer vaccine.

Merck said the FDA has agreed to conduct a priority review of Merck's application to expand the current approved usage of Gardasil -- a vaccine used to prevent infection by the human papillomavirus, or HPV -- from children and women ages 9-26 to women ages 27 through 45.

The pharmaceutical company said Gardasil is used to prevent cervical cancer, precancerous or dysplastic lesions and genital warts caused by HPV.

Gardasil, sold in some countries as Silgard, has been approved in 100 nations, including the United States, the European Union, Mexico, Australia, Taiwan, Canada, New Zealand and Brazil, Merck said.

Copyright 2008 by United Press International

Explore further: Endogenous hormones improve breast cancer risk models

add to favorites email to friend print save as pdf

Related Stories

US panel gives nod to Merck hepatitis C drug

Apr 27, 2011

A US government advisory committee on Wednesday unanimously voted to urge the Food and Drug Administration to approve a new drug made by Merck to fight hepatitis C, a disease which attacks the liver.

HPV vaccination prevents genital warts in males

Feb 04, 2011

(PhysOrg.com) -- A new international study shows the human papillomavirus (HPV) vaccine protects against genital warts and other lesions associated with HPV in males. HPV is the most common sexually transmitted disease and ...

Major international study to test new heart disease drug

Nov 18, 2010

(PhysOrg.com) -- A major international study to test whether a new type of cholesterol treatment can prevent coronary deaths and heart attacks will start in early 2011. The study will be coordinated by the ...

New drug produces steep drop in bad cholesterol

Nov 17, 2010

(AP) -- An experimental drug boosted good cholesterol so high and dropped bad cholesterol so low in a study that doctors were stunned and voiced renewed hopes for an entirely new way of preventing heart attacks ...

FDA warns of fractures with osteoporosis drugs

Oct 13, 2010

(AP) -- Government health officials warned doctors and patients Wednesday about an increased risk of thigh fractures with a widely used group of bone-strengthening drugs.

Recommended for you

Endogenous hormones improve breast cancer risk models

8 hours ago

(HealthDay)—Inclusion of endogenous hormones in prediction models improves prediction of invasive breast cancer risk in postmenopausal women, according to a study published online Aug. 18 in the Journal of ...

Novel oncogenic RET mutation found in small cell lung cancer

9 hours ago

For the first time an oncogenic somatic mutation at amino acid 918 in the RET (rearranged during transfection) protein has been identified in small cell lung cancer (SCLC) tumors and enforced expression of this mutation within ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

herpesdate
not rated yet Apr 03, 2008
HPV vaccine is useful and some HpV user at www.STDRomance.com use it